
BIOVERSE Asia 2026
Description
"Transforming drug discovery from early research to clinical application"
Highlights
Integration of AI and advanced technologies across drug discovery and development. Exploration of multi-omic insights driving digital discovery. Sessions on bio-discovery through AI. Discussion on next-generation R&D technologies. Focus on digital health and the future of AI in biological research. Designed for scientific and technology leaders advancing drug discovery. Opportunities for networking with over 20 speakers and 7+ hours of networking. Poster presentations and exhibitions of products & technology. Confirmed speakers include Rafik Fellague-Chebra from Novartis and Michael Winther from Engine Biosciences. Venue details to be announced; event to be held in Singapore.
Event location
Let your network know you`re going
Share this event to start conversations, invite colleagues, and connect before it begins.
